Article
Review article: HCV genotype 3 – the new treatment challenge.
Alimentary pharmacology & therapeutics - 1 Apr 2014
Ampuero J, Romero-Gómez M, Reddy K R
Abstract excerpt
BACKGROUND: Over the past several years, hepatitis C therapy has been pegylated interferon and ribavirin based. Although protease inhibitor-based therapy has enhanced response rates in genotype 1, the recent advances in therapy have demonstrated a challenge in genotype 3, a highly prevalent infection globally. AIM: To provide a comprehensive summary of the literature evaluating the unique characteristics and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
